Anthurium: The company will participate in the national organized drug collection agreement. When the agreement period expires, the company intends to continue the purchase of selected varieties.

Announcement from Yipinhong: Recently, our wholly-owned subsidiary Yipinhong Pharmaceutical Co., Ltd. participated in the bidding work of the national organization's drug agreement variety renewal procurement organized by the Office of Renewal Procurement of the National Organization's Drug Agreement Expiry Variety. According to the "Notice of the Planned Selection Result of the National Organization's Drug Agreement Expiry Variety Renewal Procurement" released by the Renewal Procurement Office on February 10, 2026, the company is planned to be selected for a total of 15 drug varieties in this renewal procurement.